The goals of the study are to generate new intellectual property around the potential diagnosis and treatment of neurological complications of Long COVID-19 and assess whether ATL1102, an RNA…
(PRWeb March 07, 2022)
Read the full story at https://www.prweb.com/releases/antisense_therapeutics_launches_groundbreaking_study_on_long_covid/prweb18537977.htm